BPC-157 – Comprehensive Research Overview
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a protective protein found in human gastric juice. It is one of the most extensively studied peptides in regenerative and tissue repair research due to its pleiotropic effects on healing, angiogenesis, and cytoprotection. It is frequently investigated in combination with TB-500 for synergistic regenerative outcomes.
→ View BPC-157 (for laboratory research use only)
Chemical Structure and Properties
- Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Weight: ≈ 1,419.56 Da
- Form: Lyophilized powder
- Key Feature: Highly stable in gastric acid and aqueous solutions, supporting both injectable and oral administration in research models
Mechanism of Action
BPC-157 exhibits multi-target (pleiotropic) activity:
- Upregulates VEGFR2 and activates the Akt-eNOS pathway, promoting angiogenesis and vascular repair
- Modulates inflammatory mediators (COX-2, TNF-α, IL-6) while enhancing fibroblast activity and collagen organization
- Supports cytoprotection in tendons, ligaments, muscle, gastrointestinal tract, and nervous tissue
- Influences growth hormone receptor expression and focal adhesion kinase (FAK) pathways
Research Findings
BPC-157 has a large body of preclinical evidence (>100 published studies) demonstrating accelerated healing in tendon, ligament, muscle, bone, skin, and gastrointestinal injury models. It has also been investigated in models of inflammatory bowel disease and vascular injury. While human clinical data remain limited, it continues to be one of the most actively researched compounds in tissue regeneration and cytoprotection.
→ Interested in researching BPC-157? View Product Options
Key Research Areas
- Accelerated tendon, ligament, and muscle repair
- Gastrointestinal mucosal protection and healing
- Enhanced wound healing and angiogenesis
- Reduction of inflammation and improved tissue remodeling
- Potential neuroprotective effects
Typical Research Protocols
- Common doses in literature: 250–500 μg/day (animal models, adjusted by body weight)
- Routes: Subcutaneous, intramuscular (local), or oral
- Duration: Typically 4–12 weeks in chronic injury models
- Common stacks: Frequently combined with TB-500 for broader regenerative effects
Safety Profile in Preclinical Studies
BPC-157 has shown a favorable safety profile in toxicology studies, with no observed lethal dose at high multiples of therapeutic levels. Long-term safety data in humans are not established, as it is not an approved therapeutic agent.
BPC-157 vs TB-500 vs GHK-Cu – Quick Comparison
| Aspect | BPC-157 | TB-500 | GHK-Cu |
|---|---|---|---|
| Primary Focus | Localized cytoprotection & angiogenesis | Systemic cell migration & actin remodeling | Collagen synthesis & gene expression |
| Best For | Tendons, gut, wounds | Muscle, soft tissue, fibrosis | Skin, anti-aging models |
| Administration | Oral or injectable | Injectable | Topical or injectable |
| Research Status | Extensive preclinical | Strong preclinical | Preclinical + cosmetic models |
FAQ
- Is BPC-157 FDA approved? No. It is sold strictly for laboratory research use only.
- Can it be studied orally? Yes. It is notably stable in gastric acid.
- How does it compare to TB-500? BPC-157 is often preferred for localized repair and gut models, while TB-500 excels in systemic actin regulation and cell migration.
- Can it be combined with other compounds? Yes. It is commonly studied in combination with TB-500, KPV, or other regenerative peptides.
Summary
BPC-157 is a highly stable, gastric-derived peptide that serves as a cornerstone tool in tissue repair and regenerative research. Its ability to modulate multiple healing pathways makes it valuable for studying musculoskeletal injury, gastrointestinal integrity, and vascular repair in controlled laboratory settings.
For Laboratory Research Use View BPC-157 →
Disclaimer This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. Always comply with institutional guidelines and applicable regulations.